
Jeffrey Andrew How MD
Gynecologic Oncology
Assistant Professor
Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. How is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 2019 - 2023
- McGill University Faculty of MedicineObstetrics & Gynecology, 2014 - 2019
- Harvard School of Public HealthMPH, Epidemiology, 2015 - 2017
- McGill University Faculty of MedicineClass of 2014
Certifications & Licensure
- TX State Medical License 2021 - 2027
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Publications & Presentations
PubMed
- Pembrolizumab in Patients with Advanced Miscellaneous Rare Cancers: Results from a Phase 2 Basket Trial.Mirella Nardo, Camila Braganca Xavier, Bettzy Stephen, Jeffrey A How, Justin Moyers
Journal of Immunotherapy and Precision Oncology. 2025-05-01 - Mesonephric-like adenocarcinoma of the female genital tract: Pathologic diagnosis, clinical outcomes, and novel therapeutics.Kari L Ring, Anne M Mills, Brooke E Howitt, Rachel N Grisham, Elizabeth D Euscher
Gynecologic Oncology. 2025-04-24 - A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma.Omar Alhalabi, Mohamed A Gouda, Denái R Milton, Hassan Ahmed Momin, Bulent Yilmaz
Cancer Medicine. 2025-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: